they are going into something completely unfamiliar. There is synergy. How much? We'll see. Yes ... they received a value accretive loan. That helped their share price. However, what Wall Street also acknowledges its synergy ... otherwise they wouldn't have received the massive bump in share price.

Anywhere on the value chain, you're always going to have to source materials. You can't make materials out of nothing. You think upstream semiconductor don't source materials? Other pharma companies source materials as well. It's about know how and infrastructure.

Kodak has some supposed infrastructure and chemical know how advantages that makes some sense in the pharmaceutical game. Whether they execute, is another story ... which I highlighted. However, as the CEO said ... they have the know how and infrastructure to ramp quickly. They are not going into the business blindly.

It's true. The CEO can say whatever they want ... however, if it makes no sense, he'll be punished by Wall Street. What did the stock do yesterday? Jump 200%. Obviously, the market sees some synergies. Not all financing (loans or equity) are looked favorably by the market. There has to be at least some potential for upside ... value creation.

That said, I made it clear that it was a "chemical company" ... so it made SOME sense. The poster made it appear Kodak had no chemical exposure which is wrong. Kodak didn't completely get out of the chemical business when they spun off Eastman Chemical 25 years ago. They still are affiliated with Alaris, etc.